-
1
-
-
0017698226
-
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age
-
1. Peltola H, Mäkelä PH, Käyhty H et al. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 1977; 297: 686-691.
-
(1977)
N Engl J Med
, vol.297
, pp. 686-691
-
-
Peltola, H.1
Mäkelä, P.H.2
Käyhty, H.3
-
2
-
-
0021254144
-
Prevention of Haemophilus influenzae type b bacteremic infections with the capsular poly-saccharide vaccine
-
2. Peltola H, Käyhty H, Virtanen M, Mäkelä PH. Prevention of Haemophilus influenzae type b bacteremic infections with the capsular poly-saccharide vaccine. N Engl J Med 1984; 310: 1561-1566.
-
(1984)
N Engl J Med
, vol.310
, pp. 1561-1566
-
-
Peltola, H.1
Käyhty, H.2
Virtanen, M.3
Mäkelä, P.H.4
-
3
-
-
0023204390
-
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy
-
3. Eskola J, Peltola H, Takala AK et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med 1987; 317: 717-722.
-
(1987)
N Engl J Med
, vol.317
, pp. 717-722
-
-
Eskola, J.1
Peltola, H.2
Takala, A.K.3
-
4
-
-
0027944223
-
The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program
-
4. Peltola H, Heinonen OP, Valle M et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331: 1397-1402.
-
(1994)
N Engl J Med
, vol.331
, pp. 1397-1402
-
-
Peltola, H.1
Heinonen, O.P.2
Valle, M.3
-
5
-
-
0019182071
-
Clinical and laboratory studies on combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus
-
5. Weibel RE, Carlson AJ Jr, Villarejos VM et al. Clinical and laboratory studies on combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Proc Soc Exp Biol Med 1980; 165: 323-326.
-
(1980)
Proc Soc Exp Biol Med
, vol.165
, pp. 323-326
-
-
Weibel, R.E.1
Carlson A.J., Jr.2
Villarejos, V.M.3
-
6
-
-
0019440971
-
Clinical and serological evaluation of measles, mumps, and rubella (HPV-77: DE-5 and RA 27/3) virus vaccines, singly and in combination
-
6. Lerman SJ, Bollinger M, Brunken JM. Clinical and serological evaluation of measles, mumps, and rubella (HPV-77: DE-5 and RA 27/3) virus vaccines, singly and in combination. Pediatrics 1981; 68: 18-22.
-
(1981)
Pediatrics
, vol.68
, pp. 18-22
-
-
Lerman, S.J.1
Bollinger, M.2
Brunken, J.M.3
-
7
-
-
0020559948
-
Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: First experience
-
7. Christenson B, Böttiger M, Heller L et al. Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. Brit Med J 1983; 287: 389-391.
-
(1983)
Brit Med J
, vol.287
, pp. 389-391
-
-
Christenson, B.1
Böttiger, M.2
Heller, L.3
-
8
-
-
0021268181
-
Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children
-
8. Vesikari T, Ala-Laurila E-L, Heikkinen A et al. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Am J Dis Child 1984; 138: 843-847.
-
(1984)
Am J Dis Child
, vol.138
, pp. 843-847
-
-
Vesikari, T.1
Ala-Laurila, E.-L.2
Heikkinen, A.3
-
9
-
-
0022577614
-
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind, placebo-controlled trial in twins
-
9. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind, placebo-controlled trial in twins. Lancet 1986; 1: 939-942.
-
(1986)
Lancet
, vol.1
, pp. 939-942
-
-
Peltola, H.1
Heinonen, O.P.2
|